Brief: Terns Pharmaceuticals Says Safety Profile Maintained With Longer Treatment Duration
08/12/2025 20:53
Dec 8 (Reuters) - Terns Pharmaceuticals Inc TERN.O: TERNS PHARMACEUTICALS INC - SAFETY PROFILE MAINTAINED WITH LONGER TREATMENT DURATION Source text: ID:nGNX5DQgPN Further company coverage: TERN.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Terns Pharmaceuticals
See all newsNASDAQ TRADE HALT REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
U.S. RESEARCH ROUNDUP-East West Bancorp, Reliance, S&P Global
Brief: Merck Announces Expiration Of Hart-Scott-Rodino Act Waiting Period To Acquire Terns Pharmaceuticals
Brief: Merck Begins Tender Offer To Acquire Terns Pharmaceuticals, Inc.